(PD142943) Támogató: Kulturális és Innovációs Minisztérium Nemzeti Kutatási Fejlesztési
és Innovációs Alap
OTKA(FK142971)
(PC-II-12/2022)
Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015)
Támogató: NKFIH
Pheochromocytomas and paragangliomas (PPGL) are classified as rare cancers but can
be highly metastatic, particularly in individuals with inherited succinate dehydrogenase
B (SDHB) mutations. As current therapies and the availability of SDHB-deficient animal
models are both limited, we have previously constructed a nematode PPGL model, a transgenic
worm carrying the R244H missense mutation equivalent to human R230H in the sdhb-1
gene. In this study, we show that R244H mutants display characteristics of PPGL tumors,
such as pseudohypoxia activation and the accumulation of reactive oxygen species.
The latter can be the result of compromised antioxidant machinery, as R244H mutants
have reduced levels of cytosolic and mitochondrial superoxide dismutase enzymes. In
addition, the expression of mitophagy markers pink-1 (PTEN-induced putative kinase)
and pdr-1 (E3 ubiquitin-protein ligase parkin) were downregulated in R244H mutants,
suggesting impaired mitophagy and reflecting the crucial role of mitochondrial health
in PPGL pathology. Treatments by the SDH inhibitor fluopyram revealed that the SDH
complex carrying the R244H mutation in subunit B displayed residual SDH activity,
which was also confirmed by our structural analyses. We also observed a link between
dopaminergic neuronal health and SDHB-1.